StageZero Life Sciences (SZLSF) Short Interest Ratio & Short Volume $0.0030 0.00 (0.00%) As of 04/29/2025 Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock StageZero Life Sciences Short Interest DataStageZero Life Sciences (SZLSF) has a short interest of 2,400 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 1,906 shares to cover all short positions.Current Short Interest2,400 sharesPrevious Short Interest2,400 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$3.84Short Interest Ratio1.3 Days to CoverLast Record DateJanuary 15, 2025Outstanding Shares123,533,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume1,906 sharesToday's Volume Vs. Average0% Short Selling StageZero Life Sciences? Sign up to receive the latest short interest report for StageZero Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSZLSF Short Interest Over TimeSZLSF Days to Cover Over TimeSZLSF Percentage of Float Shorted Over Time StageZero Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20252,400 shares $3.84 No ChangeN/A1.3 $0.00 12/31/20242,400 shares $3.84 No ChangeN/A2 $0.00 12/15/20242,400 shares $3.84 No ChangeN/A1.6 $0.00 11/30/20242,400 shares $3.84 No ChangeN/A0.2 $0.00 11/15/20242,400 shares $58.50 No ChangeN/A24 $0.02 10/31/20242,400 shares $190.68 No ChangeN/A0.4 $0.08 10/15/20242,400 shares $219.84 No ChangeN/A1.5 $0.09 9/30/20242,400 shares $96.00 -76.9%N/A0.2 $0.04 9/15/202410,400 shares $832.00 -22.4%N/A8.7 $0.08 8/31/202413,400 shares $670.00 -33.3%N/A1.2 $0.05 Get the Latest News and Ratings for SZLSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/15/202420,100 shares $804.00 +30.5%N/A2.2 $0.04 7/31/202415,400 shares $320.32 No ChangeN/A6.4 $0.02 7/15/202415,400 shares $231.00 No ChangeN/A22 $0.02 6/30/202415,400 shares $23.10 -5.5%N/A15.4 $0.00 6/15/202416,300 shares $195.60 No ChangeN/A7.1 $0.01 5/31/202416,300 shares $652.00 No ChangeN/A40.8 $0.04 5/15/202416,300 shares $208.64 -31.8%N/A9.1 $0.01 4/30/202423,900 shares $956.00 +3.9%N/A7.5 $0.04 4/15/202423,000 shares $662.40 -1.3%N/A0.1 $0.03 3/31/202423,300 shares $816.67 No ChangeN/A1.4 $0.04 3/15/202423,300 shares $629.10 -0.9%N/A8 $0.03 2/29/202423,500 shares $728.50 -1.3%N/A16.8 $0.03 2/15/202423,800 shares $716.38 -19.1%N/A9.2 $0.03 1/15/202429,400 shares $961.38 +10.1%N/A6.7 $0.03 12/31/202326,700 shares $784.98 -2.9%N/A3.3 $0.03 12/15/202327,500 shares $863.50 -6.8%N/A8.3 $0.03 11/30/202329,500 shares $976.45 +555.6%N/A1.5 $0.03 11/15/20234,500 shares $151.65 -39.2%N/A5.6 $0.03 10/31/20237,400 shares $271.58 +208.3%N/A3.4 $0.04 10/15/20232,400 shares $86.64 No ChangeN/A0.3 $0.04 9/30/20232,400 shares $96.96 No ChangeN/A0.5 $0.04 9/15/20232,400 shares $103.80 No ChangeN/A0 $0.04 8/31/20232,400 shares $103.80 No ChangeN/A4.3 $0.04 8/15/20232,400 shares $118.80 -46.7%N/A3.4 $0.05 7/31/20234,500 shares $212.85 No ChangeN/A1.7 $0.05 7/15/20234,500 shares $203.85 +87.5%N/A9 $0.05 6/30/20232,400 shares $110.76 No ChangeN/A8 $0.05 6/15/20232,400 shares $112.08 No ChangeN/A1.8 $0.05 5/31/20232,400 shares $102.86 -73.3%N/A0.6 $0.04 5/15/20239,000 shares $569.70 No ChangeN/A22.5 $0.06How to invest in Elon Musk’s Optimus before its launch (Ad)Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.Get all the information here. 4/30/20239,000 shares $569.70 No ChangeN/A6 $0.06 4/15/20239,000 shares $544.50 -69.9%N/A1.1 $0.06 3/31/202329,900 shares $1,964.43 -0.3%N/A149.5 $0.07 3/15/202330,000 shares $2,505.00 +934.5%N/A3.3 $0.08 2/28/20232,900 shares $295.51 -14.7%N/A0.1 $0.10 2/15/20233,400 shares $199.92 -46.9%N/A0.3 $0.06 1/31/20236,400 shares $327.04 +45.5%N/A1.5 $0.05 1/15/20234,400 shares $220.66 No ChangeN/A8.8 $0.05 12/30/20224,400 shares $194.92 No ChangeN/A0.5 $0.04 12/15/20224,400 shares $234.08 -31.3%N/A1.2 $0.05 11/30/20226,400 shares $338.56 -13.5%N/A1.5 $0.05 11/15/20227,400 shares $439.82 -11.9%N/A1.3 $0.06 10/31/20228,400 shares $479.98 -5.6%N/A0 $0.06 10/15/20228,900 shares $508.55 No ChangeN/A89 $0.06 9/30/20228,900 shares $508.55 -5.3%N/A1.3 $0.06 9/15/20229,400 shares $589.38 No ChangeN/A18.8 $0.06 8/31/20229,400 shares $648.60 -9.6%N/A7.8 $0.07 8/15/202210,400 shares $676.00 -35.4%N/A0.6 $0.07 7/31/202216,100 shares $1,006.25 +0.6%N/A8.5 $0.06 7/15/202216,000 shares $968.00 -60.3%N/A3.3 $0.06 6/30/202240,300 shares $2,579.20 -32.0%N/A13.4 $0.06 6/15/202259,300 shares $3,670.67 -1.7%N/A8.7 $0.06 5/31/202260,300 shares $4,287.33 No ChangeN/A19.5 $0.07 5/15/202260,300 shares $4,727.52 +238.8%N/A50.3 $0.08 4/30/202217,800 shares $1,329.66 +44.7%N/A0.8 $0.07 4/15/202212,300 shares $1,060.26 -3.9%N/A0.4 $0.09 3/31/202212,800 shares $1,816.32 -69.6%N/A2 $0.14 3/15/202242,100 shares $6,900.19 -43.9%N/A3.1 $0.16 2/28/202275,100 shares $11,640.50 -16.5%N/A46.9 $0.16 2/15/202289,900 shares $17,458.58 -0.3%N/A17.6 $0.19 1/31/202290,200 shares $16,957.60 +14.6%N/A10 $0.19 1/15/202278,700 shares $18,876.20 -0.6%N/A5.2 $0.24 12/31/202179,200 shares $18,239.76 -3.1%N/A9.5 $0.23 12/15/202181,700 shares $18,791.00 +181.7%N/A8.8 $0.23 11/30/202129,000 shares $7,577.70 +205.3%N/A0.5 $0.26 11/15/20219,500 shares $2,375.00 -81.5%N/A1 $0.25 10/29/202151,300 shares $14,364.00 +5.1%N/A0.5 $0.28 10/15/202148,800 shares $14,640.00 No ChangeN/A13.6 $0.30 9/30/202148,800 shares $14,654.64 -27.4%N/A5.4 $0.30 9/15/202167,200 shares $21,524.16 -34.1%N/A12.2 $0.32 8/31/2021101,900 shares $32,852.56 -29.7%N/A15.7 $0.32 8/13/2021144,900 shares $51,120.72 No ChangeN/A20.4 $0.35 7/30/2021144,900 shares $51,135.21 +1.1%N/A27.9 $0.35 7/15/2021143,400 shares $0.00 No ChangeN/A22.4 $0.00 SZLSF Short Interest - Frequently Asked Questions What is StageZero Life Sciences' current short interest? Short interest is the volume of StageZero Life Sciences shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 2,400 shares of SZLSF short. Learn More on StageZero Life Sciences' current short interest. What is a good short interest ratio for StageZero Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SZLSF shares currently have a short interest ratio of 1.0. Learn More on StageZero Life Sciences's short interest ratio. How does StageZero Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to StageZero Life Sciences: Virax Biolabs Group Limited (6.39%), Aspira Women's Health Inc. (1.19%), IDEXX Laboratories, Inc. (3.74%), Ipsen S.A. (0.00%), Lantheus Holdings, Inc. (10.23%), QuidelOrtho Co. (5.71%), Celldex Therapeutics, Inc. (13.76%), Neogen Co. (12.20%), Intellia Therapeutics, Inc. (28.92%), Myriad Genetics, Inc. (5.79%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.18 billion), Charter Communications, Inc. ($3.91 billion), Reddit, Inc. ($3.16 billion), The Kroger Co. ($2.75 billion), International Paper ($2.57 billion), Cencora, Inc. ($2.06 billion), SoFi Technologies, Inc. ($2.06 billion), Rivian Automotive, Inc. ($2.00 billion), Live Nation Entertainment, Inc. ($1.63 billion), and Hims & Hers Health, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short StageZero Life Sciences stock? Short selling SZLSF is an investing strategy that aims to generate trading profit from StageZero Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against StageZero Life Sciences? A short squeeze for StageZero Life Sciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SZLSF, which in turn drives the price of the stock up even further. How often is StageZero Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SZLSF, twice per month. The most recent reporting period available is January, 15 2025. More Short Interest Resources from MarketBeat Related Companies VRAX Short Squeeze AWH Short Squeeze BGMD Short Squeeze IDXX Short Squeeze IPSEY Short Squeeze LNTH Short Squeeze QDEL Short Squeeze CLDX Short Squeeze NEOG Short Squeeze NTLA Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SZLSF) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThe Worst Year in American Financial History?Economist Explains: The Curse on the U.S. Dollar Yes, there is a Curse on the U.S. Dollar... and it's behin...Stansberry Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share StageZero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.